1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | Aug 2025 | |
|---|---|---|
| Revenue | 6.63K | - |
| Gross profit | -42.77K | - |
| Net profit | -937.85K | - |
| EBITDA | -937.85K | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €594.85K |
Number of shares | 13.52M |
52-week high/low | €0.39 - €0.0164 |
| Dividends | No |
Beta | 1.70 |
P/E ratio | -0.41 |
PEG ratio | 0.00 |
P/B ratio | 1.22 |
P/S ratio | 0.09 |
Company profile
SOL Global Investments Corp. ist eine Kapitalanlagegesellschaft mit Schwerpunkt auf der biopharmazeutischen und Cannabis-Industrie in den Vereinigten Staaten. Das Unternehmen war früher als Scythian Biosciences Corp. bekannt und änderte im Oktober 2018 seinen Namen in SOL Global Investments Corp. SOL Global Investments Corp. hat seinen Sitz in Toronto, Kanada.
| Name | SOL Global Investments |
| CEO | Pad Gopal |
| Headquarters | Toronto,
on Canada |
| Website | |
| Sector | Financials |
| Industry | Financial Services |
| IPO | 03/05/2018 |
| Employees | 5 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Pnk | SOLCF |
Cnq | SOL.CN |
Frankfurt | 9SB.F |
München | 9SB.MU |
Düsseldorf | 9SB.DU |
Discover assets
Shareholders of SOL Global Investments also invest in the following assets
